125 related articles for article (PubMed ID: 7189572)
21. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders.
Thiele J; Kvasnicka HM
Semin Thromb Hemost; 2006 Apr; 32(3):219-30. PubMed ID: 16673276
[TBL] [Abstract][Full Text] [Related]
22. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
[TBL] [Abstract][Full Text] [Related]
23. [Clinical case. Primary thrombocythemia].
Pozzato G; Terpin MM; Rinaldi C; Frezza M
G Clin Med; 1987 Feb; 68(2):121-3. PubMed ID: 3609602
[No Abstract] [Full Text] [Related]
24. [Some questions on the problem of thrombocythemia].
Frinovskaia IV
Probl Gematol Pereliv Krovi; 1968 Nov; 13(11):7-13. PubMed ID: 5753808
[No Abstract] [Full Text] [Related]
25. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
26. Busulfan in early pregnancy.
Williams DW
Obstet Gynecol; 1966 May; 27(5):738-40. PubMed ID: 5220059
[No Abstract] [Full Text] [Related]
27. Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan.
Bensinger TA; Logue GL; Rundles RW
Blood; 1970 Jul; 36(1):61-9. PubMed ID: 5463461
[No Abstract] [Full Text] [Related]
28. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; van Urk H
Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
[TBL] [Abstract][Full Text] [Related]
29. [Primary hemorrhagic thrombocythemia. 3 cases].
Torre-Lopez E; Sanchez-Medal L
Sangre (Barc); 1971; 16(3):305-13. PubMed ID: 5287077
[No Abstract] [Full Text] [Related]
30. [Acute myeloid leukemia developing in the course of essential thrombocythemia].
Fernández MC; Gardelegui I; Capote FJ; Gil JL; Muñoz JA
Sangre (Barc); 1996 Oct; 41(5):405-6. PubMed ID: 9026932
[No Abstract] [Full Text] [Related]
31. [Interferon therapy in essential thrombocythemia].
Seewann HL
Wien Med Wochenschr; 1993; 143(16-17):420-4. PubMed ID: 8273365
[TBL] [Abstract][Full Text] [Related]
32. Defining targets in myeloproliferative disorders: reflecting on what is important.
Griesshammer M
Hematol Oncol; 2009 Jun; 27 Suppl 1():2-4. PubMed ID: 19468984
[TBL] [Abstract][Full Text] [Related]
33. Intermittent melphalan in the treatment of essential thrombocytosis with haemorrhage or thrombosis.
de Pauw BE; van Bergen AN; Haanen C; Steenbergen J
Scand J Haematol; 1985 Oct; 35(4):448-50. PubMed ID: 4081643
[TBL] [Abstract][Full Text] [Related]
34. Interferon-alpha for treatment of essential thrombocythemia during pregnancy: case report and review of the literature.
Séror J; Sentilhes L; Lefebvre-Lacoeuille C; Marpeau L
Fetal Diagn Ther; 2009; 25(1):136-40. PubMed ID: 19279390
[TBL] [Abstract][Full Text] [Related]
35. Primary thrombocythemia in a child.
Sceats DJ; Baitlon D
Clin Pediatr (Phila); 1980 Apr; 19(4):298-300. PubMed ID: 7357787
[No Abstract] [Full Text] [Related]
36. [Essential thrombocytosis--a criteria diagnosis. Important to differentiate from reactive/secondary thrombocytosis].
Andreasson B; Johansson P; Samuelsson J
Lakartidningen; 2009 Jan 14-20; 106(3):110-3. PubMed ID: 19248460
[No Abstract] [Full Text] [Related]
37. Isolated spleen agenesis: a rare cause of thrombocytosis mimicking essential thrombocythemia.
Chanet V; Tournilhac O; Dieu-Bellamy V; Boiret N; Spitz P; Baud O; Darcha C; Travade P; Laurichesse H
Haematologica; 2000 Nov; 85(11):1211-3. PubMed ID: 11064471
[TBL] [Abstract][Full Text] [Related]
38. [Therapy of blast crises in megakaryocytic myelosis].
Zurborn KH; Bruhn HD; Feller A
Dtsch Med Wochenschr; 1984 Apr; 109(14):556-7. PubMed ID: 6538475
[No Abstract] [Full Text] [Related]
39. Primary or hemorrhagic thrombocythemia.
Silverstein MN
Arch Intern Med; 1968 Jul; 122(1):18-22. PubMed ID: 5301705
[No Abstract] [Full Text] [Related]
40. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
